Emyria in ‘final stages’ of winding down Emerald Clinics by Steve Jones September 3, 2024September 3, 2024 Emyria is winding down its cannabis clinic business to focus on MDMA-assisted therapy as its chief […]
Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024
Company news: Cann Compounding; Ecofibre; Ora Pharm; Althea; Melodiol Global Health; Wellnex Life; Emyria by Martin Lane and Steve Jones April 24, 2024April 24, 2024
Emyria inks deal to study MDMA-assisted therapy for first responders by Martin Lane April 3, 2024July 16, 2024
Company news: Zelira; ECS Botanics; LGP; Ecofibre; Neurotech; Elixinol; Emyria by Steve Jones and Martin Lane February 28, 2024July 16, 2024
Emyria S3 CBD trial ‘on hold’ as firm stresses need to focus on revenue by Steve Jones February 7, 2024February 7, 2024
